Vladimir S. Shavva

Vladimir S. Shavva

Auto-generated profile, based on publicly available information

Vladimir S. Shavva

Department of Biochemistry, Institute of Experimental Medicine, Russian Academy of Medical Sciences, St. Petersburg, Russia

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 November 2009 in Biochemistry
Verified
Journal Article
Closed access
DMDenis A. Mogilenko
Denis A. Mogilenko
EDElla B. Dizhe
Ella B. Dizhe
VSVladimir S. Shavva
Vladimir S. Shavva
ILIvan A. Lapikov
Ivan A. Lapikov
SOSergey V. Orlov
Sergey V. Orlov
APAndrey P. Perevozchikov
Andrey P. Perevozchikov

1 February 2012 in Journal of Biological Chemistry
Verified
Journal Article
Open access
DMDenis A. Mogilenko
Denis A. Mogilenko
IKIgor V. Kudriavtsev
Igor V. Kudriavtsev
ATAndrey S. Trulioff
Andrey S. Trulioff
VSVladimir S. Shavva
Vladimir S. Shavva
EDElla B. Dizhe
Ella B. Dizhe
SOSergey V. Orlov
Sergey V. Orlov
Complement C3 is a pivotal component of three cascades of complement activation. C3 is expressed in human atherosclerotic lesions and is involved in atherogenesis. However, the mechanism of C3 accumulation in atherosclerotic lesions is not well elucidated. We show that acetylated low density lipoprotein and oxidized low density lipoprotein (oxLDL) increase C3 gene expression and protein secretion by human macrophages. Modified LDL (mLDL)-mediated activation of C3 expression mainly depends on liver X receptor (LXR) and partly on Toll-like receptor 4 (TLR4), whereas C3 secretion is increased due to TLR4 activation by mLDL. LXR agonist TO901317 stimulates C3 gene expression in human monocyte-macrophage cells but not in human hepatoma (HepG2) cells. We find LXR-responsive element inside of the promoter region of the human C3 gene, which binds to LXRβ in macrophages but not in HepG2 cells. We show that C3 expression and secretion is decreased in IL-4-treated (M2) and increased in IFNγ/LPS-stimulated (M1) human macrophages as compared with resting macrophages. LXR agonist TO901317 potentiates LPS-induced C3 gene expression and protein secretion in macrophages, whereas oxLDL differently modulates LPS-mediated regulation of C3 in M1 or M2 macrophages. Treatment of human macrophages with anaphylatoxin C3a results in stimulation of C3 transcription and secretion as well as increased oxLDL accumulation and augmented oxLDL-mediated up-regulation of the C3 gene. These data provide a novel mechanism of C3 gene regulation in macrophages and suggest new aspects of cross-talk between mLDL, C3, C3a, and TLR4 during development of atherosclerotic lesions.

1 January 2013 in Journal of Biological Chemistry
Verified
Journal Article
Open access
DMDenis A. Mogilenko
Denis A. Mogilenko
IKIgor V. Kudriavtsev
Igor V. Kudriavtsev
VSVladimir S. Shavva
Vladimir S. Shavva
EDElla B. Dizhe
Ella B. Dizhe
EVEkaterina G. Vilenskaya
Ekaterina G. Vilenskaya
SOSergey V. Orlov
Sergey V. Orlov
Complement C3 is a pivotal component of three cascades of complement activation. The liver is the main source of C3 in circulation and expression and secretion of C3 by hepatocytes is increased during acute inflammation. However, the mechanism of the regulation of the C3 gene in hepatocytes is not well elucidated. We showed that the C3 gene is the direct target for peroxisome proliferator-activated receptor α (PPARα) in human hepatoma HepG2 cells and mouse liver. Using PPARα siRNA and synthetic PPARα agonist WY-14643 and antagonist MK886 we showed that activation of PPARα results in up-regulation of C3 gene expression and protein secretion by HepG2 cells. The PPAR response element (PPRE), which is able to bind PPARα in vitro and in vivo, was found in the human C3 promoter. PPRE is conserved between human and mouse, and WY-14643 stimulates mouse C3 expression in the liver. TNFα increases C3 gene via NF-κB and, to a lesser extent, MEK1/2 signaling pathways, whereas TNFα-mediated stimulation of C3 protein secretion depends on activation of MEK1/2, p38, and JNK in HepG2 cells. Activation of PPARα abolishes TNFα-mediated up-regulation of C3 gene expression and protein secretion due to interference with NF-κB via PPRE-dependent mechanism in HepG2 cells. TNFα decreases PPARα protein content via NF-κB and MEK1/2 signaling pathways and inhibits PPARα binding with the human C3 promoter in HepG2 cells. These results suggest novel mechanism controlling C3 expression in hepatocytes during acute phase inflammation and demonstrate a crosstalk between PPARα and TNFα in the regulation of complement system.

23 January 2012 in The FASEB Journal
Verified
Journal Article
Open access
PDF file
DMDenis A. Mogilenko
Denis A. Mogilenko
SOSergey V. Orlov
Sergey V. Orlov
ATAndrey S. Trulioff
Andrey S. Trulioff
AIAndrei V. Ivanov
Andrei V. Ivanov
VNVadim K. Nagumanov
Vadim K. Nagumanov
APAndrej P. Perevozchikov
Andrej P. Perevozchikov
Apolipoprotein A‐I (ApoA‐I) is the main functional protein component of human high‐density lipoproteins. ApoA‐I shows various anti‐inflammatory and atheroprotective properties toward macrophages; however, endogenous apoA‐I expression has not been investigated in macrophages. We have shown that endogenous apoA‐I gene is expressed in human macrophages at both mRNA and protein levels. Endogenous ApoA‐I is localized in intracellular vesicles and at the external side of the plasma membrane in association with ATP‐binding cassette transporter A1 (ABCA1) and lipid rafts in macrophages. We have shown that endogenous ApoA‐I stabilizes ABCA1, moreover, down‐regulation of ApoA‐I by siRNA results in an increase of Toll‐like receptor 4 (TLR4) mRNA and membrane surface protein expression, as well as an enhancement of bacterial lipopolysaccharide (LPS)‐induced expression of tumor necrosis factor‐α (TNF‐α), interleukin 1β (IL‐1β), and inducible nitric oxide synthase (NOS2) genes in human macrophages. TNF‐α stimulates ApoA‐I expression and secretion (1.2±0.2 vs. 4.3±0.9 ng/mg total protein) in macrophages. Obtained results suggest that endogenous ApoA‐I has anti‐inflammatory properties, presumably due to ABCA1 stabilization in macrophages; these results elucidate the cell type‐specific mechanism of the TNF‐α‐mediated regulation of apoA‐I gene expression in monocytes and macrophages.—Mogilenko, D. A., Orlov, S. V., Trulioff, A. S., Ivanov, A. V., Nagumanov, V. K., Kudriavtsev, I. V., Shavva, V. S., Tanyanskiy, D. A., Perevozchikov, A. P. Endogenous apolipoprotein A‐I stabilizes ATP‐binding cassette transporter A1 and modulates Toll‐like receptor 4 signaling in human macrophages. FASEB J. 26, 2019‐2030 (2012). www.fasebj.org

29 March 2023 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
LTLaura Tarnawski
Laura Tarnawski
VSVladimir S. Shavva
Vladimir S. Shavva
EKEric J. Kort
Eric J. Kort
ZZZhengbing Zhuge
Zhengbing Zhuge
INIngrid Nilsson
Ingrid Nilsson
POPeder S. Olofsson
Peder S. Olofsson
Endothelial dysfunction and impaired vasodilation are linked with adverse cardiovascular events. T lymphocytes expressing choline acetyltransferase (ChAT), the enzyme catalyzing biosynthesis of the vasorelaxant acetylcholine (ACh), regulate vasodilation and are integral to the cholinergic antiinflammatory pathway in an inflammatory reflex in mice. Here, we found that human T cell ChAT mRNA expression was induced by T cell activation involving the PI3K signaling cascade. Mechanistically, we identified that ChAT mRNA expression was induced following the attenuation of RE-1 Silencing Transcription factor REST-mediated methylation of the ChAT promoter, and that ChAT mRNA expression levels were up-regulated by GATA3 in human T cells. In functional experiments, T cell-derived ACh increased endothelial nitric oxide-synthase activity, promoted vasorelaxation, and reduced vascular endothelial activation and promoted barrier integrity by a cholinergic mechanism. Further, we observed that survival in a cohort of patients with severe circulatory failure correlated with their relative frequency of ChAT  + CD4 + T cells in blood. These findings on ChAT + human T cells provide a mechanism for cholinergic immune regulation of vascular endothelial function in human inflammation.

1 November 2010 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
DMDenis A. Mogilenko
Denis A. Mogilenko
VSVladimir S. Shavva
Vladimir S. Shavva
EDElla B. Dizhe
Ella B. Dizhe
SOSergey V. Orlov
Sergey V. Orlov
APAndrej P. Perevozchikov
Andrej P. Perevozchikov